We are live on ! Find out more
BIOSW

BioPlus Acquisition Corp. Warrants
BIOSW

Delisted

BIOSW was delisted on the 6th of October, 2023.

Back to rankings

43 hedge funds and large institutions have $5.67M invested in BioPlus Acquisition Corp. Warrants in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 45 → 43 (-2)

26% less capital invested

Capital invested by funds: $7.66M → $5.67M (-$1.99M)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
43
Holders Change
-2
Holders Change %
-4.44%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
5
Closed
3
Calls
$2M
Puts
–
Net Calls
+$2M
Net Calls Change
+$35K

Top Buyers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
+$4.09K
2
TI
Tidal Investments
Wisconsin
+$1.17K

Top Sellers

Rank Fund Capital Flow
1
CS
Clear Street
New York
-$45.2K
2
FIG
Fortress Investment Group
New York
-$9.26K
3
CAC
Cowen and Company
New York
-$3.07K
4
MP
Mangrove Partners
Connecticut
-$2.27K
5
AA
AQR Arbitrage
Connecticut
-$1.2K

BIOSW Hedge Fund Activity: Q1 2023 in Review

43 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Warrants (BIOSW) for Q1 2023, worth a combined $5.67M — down 26% from $7.66M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BIOSW and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 1 added.

The largest buyer was Shaolin Capital Management, adding an estimated $4.09K. The largest seller was Clear Street, cutting an estimated $45.2K.

  • 43 institutional investors held BioPlus Acquisition Corp. Warrants (BIOSW) as of Q1 2023, down from 45 in Q4 2022.
  • Funds reported $5.67M of BioPlus Acquisition Corp. Warrants stock for Q1 2023, down 26% quarter-over-quarter.
  • 2 funds opened new BioPlus Acquisition Corp. Warrants positions in Q1 2023 and 3 closed out, a net change of -1 holder.
  • The largest BioPlus Acquisition Corp. Warrants buyer in Q1 2023 was Shaolin Capital Management, an estimated $4.09K added.
  • The largest BioPlus Acquisition Corp. Warrants seller in Q1 2023 was Clear Street, an estimated $45.2K sold.

Based on aggregated 13F filings for Q1 2023.